22 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
12 Feb 24
Regulation FD Disclosure
4:15pm
activities of those cells that support specific disease-modifying mechanisms, such as immunomodulation, anti-inflammation, and regeneration. Celularity’s … amniotic membrane derived from the placenta of a healthy, full-term pregnancy that provides a foundation for the wound regeneration process and acts
424B5
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Prospectus supplement for primary offering
4:24pm
extracellular matrix that provides a foundation for the wound regeneration process and acts as a scaffold for restoration of functional tissue
424B3
CELU
Celularity Inc - Ordinary Shares
2 Jun 23
Prospectus supplement
5:00pm
extracellular matrix that provides a foundation for the wound regeneration process and acts as a scaffold for restoration of functional tissue. Interfyl is human
8-K
EX-99.1
4y9 763l9zzpt8tu
31 May 23
THE NEXT EVOLUTION IN CELLULAR MEDICINE Investor Presentation June 2023
5:08pm
424B5
uyfqnlo67emn6p
6 Apr 23
Prospectus supplement for primary offering
9:03pm
424B3
1316ji3or
1 Jun 22
Prospectus supplement
4:06pm
424B3
mooefgm27c 7wb17d4e
3 May 22
Prospectus supplement
4:06pm
POS AM
z5fkn7
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
vdn76 ey9trzq
12 Aug 21
Prospectus supplement
4:21pm